Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ.
Louisa Lisa LoRoger Laughlin MilneYuyan LiaoJack CuzickMary Beth TerryKelly-Anne PhillipsPublished in: British journal of cancer (2018)
Clinicians should understand that IBIS-RET Version 7.2 may overestimate 10-year invasive BC risk for Australian women with LCIS. The newer IBIS-RET Version 8.0, released September 2017, includes mammographic density and may perform better, but validation is needed.